非布索坦是哪产的？

It is a gout drug that has become a "new favorite" in recent years. Febuxostat was first launched in Europe in 2008 and was approved for marketing in China in 2013. In the following years, it became the choice of more and more gout friends with its "better acid-lowering effect and higher safety".

Febuxostat is a drug that inhibits the production of uric acid. These drugs will cause more or less side effects on the human body. For example, long-term use of benzbromarone may cause kidney damage, and allopurinol will damage the liver. Febuxostat is the latest drug with the smallest side effects. Of course, Febuxostat is also the most expensive.

Febuxostat is also known as Febuxostat. Febuxostat and Febuxostat are the same drug. They are just called differently due to translation issues. Febuxostat is a new, highly effective, selective inhibitor of non-purine xanthine oxidase, a key enzyme that promotes uric acid production. Febuxostat is the latest XOR inhibitor developed in the world. It acts on this oxidase highly selectively, reducing the synthesis of uric acid in the body and lowering the concentration of uric acid, thereby effectively treating ventilation diseases. 

  So, where is febuxostat produced?

It is understood that the manufacturer of febuxostat is Teijin Corporation of Japan.

Febuxostat is a new generation of xanthine oxidase inhibitors, clinically used to treat hyperuricemia (gout Chemicalbook). Its structure is completely different from the xanthine oxidase inhibitor drugs developed 40 years ago. It is a new and highly efficient non-purine xanthine oxidase selective inhibitor.

After it was developed and launched in Japan, it was later launched by many pharmaceutical companies in various countries around the world. Japan's Teijin Pharmaceutical has also authorized Takeda Pharmaceutical to market it in the United States, and Ipsen Company has marketed it in Europe.

In addition to Febuxostat produced by Teijin Pharmaceuticals in Japan, there are also generic versions of Febuxostat. There is an Indian version. Astellas in France is also authorized by Teijin and is also a generic version.